← Open Payments lookup

CARISSA EARL: Open Payments

NPI 1346995842 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$469 in 29 payments from 12 companies in 2025. Trend: 2023 $456 · 2024 $379 · 2025 $469

Food & beverage: $469
CompanyPaymentsAmount
ABBVIE INC.17$245
Janssen Pharmaceuticals, Inc2$35
Otsuka America Pharmaceutical, Inc.1$27
Boehringer Ingelheim Pharmaceuticals, Inc.1$25
Edwards Lifesciences Corporation1$25
Amgen Inc.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17
Merck Sharp & Dohme LLC1$17
Supernus Pharmaceuticals, Inc.1$15
Novo Nordisk Inc1$14

Products named: QULIPTA, VRAYLAR, UBRELVY, SPRAVATO, REXULTI, JARDIANCE, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), KRYSTEXXA.

Industry payments across UT — which companies pay providers there.